Brain Tumor Diagnosis and Therapeutics Market - Global Outlook and Forecast 2022-2028

January 2022 | 71 pages | ID: B122BE691928EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Brain Tumor Diagnosis and Therapeutics in Global, including the following market information:

Global Brain Tumor Diagnosis and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Brain Tumor Diagnosis and Therapeutics market was valued at 598.7 million in 2021 and is projected to reach US$ 912.2 million by 2028, at a CAGR of 6.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

MRI Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Brain Tumor Diagnosis and Therapeutics include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Merck & Co. and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Tumor Diagnosis and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Brain Tumor Diagnosis and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Brain Tumor Diagnosis and Therapeutics Market Segment Percentages, by Type, 2021 (%)

• MRI
• CT Scan
• Tissue Sampling
• PET-CT Scan
• Cerebral Arteriogram
• Lumbar Puncture
• Molecular Testing
• EEG

Global Brain Tumor Diagnosis and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Brain Tumor Diagnosis and Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Surgery
• Radiation Therapy
• Chemotherapy
• Immunotherapy
• Targeted Therapy

Global Brain Tumor Diagnosis and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Brain Tumor Diagnosis and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Brain Tumor Diagnosis and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Brain Tumor Diagnosis and Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GE Healthcare
• Hitachi
• Philips Healthcare
• Siemens Healthineers
• Toshiba Corporation
• Fujifilm Corporation
• Shimadzu Corporation
• Merck & Co.
• AstraZeneca
• Bristol Myer Squibb
• Novartis
• Roche Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Brain Tumor Diagnosis and Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Brain Tumor Diagnosis and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Brain Tumor Diagnosis and Therapeutics Market Size: 2021 VS 2028
2.2 Global Brain Tumor Diagnosis and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Brain Tumor Diagnosis and Therapeutics Players in Global Market
3.2 Top Global Brain Tumor Diagnosis and Therapeutics Companies Ranked by Revenue
3.3 Global Brain Tumor Diagnosis and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Brain Tumor Diagnosis and Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Brain Tumor Diagnosis and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Tumor Diagnosis and Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Brain Tumor Diagnosis and Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Brain Tumor Diagnosis and Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Brain Tumor Diagnosis and Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 MRI
  4.1.3 CT Scan
  4.1.4 Tissue Sampling
  4.1.5 PET-CT Scan
  4.1.6 Cerebral Arteriogram
  4.1.7 Lumbar Puncture
  4.1.8 Molecular Testing
  4.1.9 EEG
4.2 By Type - Global Brain Tumor Diagnosis and Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Brain Tumor Diagnosis and Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Brain Tumor Diagnosis and Therapeutics Market Size, 2021 & 2028
  5.1.2 Surgery
  5.1.3 Radiation Therapy
  5.1.4 Chemotherapy
  5.1.5 Immunotherapy
  5.1.6 Targeted Therapy
5.2 By Application - Global Brain Tumor Diagnosis and Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Brain Tumor Diagnosis and Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Brain Tumor Diagnosis and Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Brain Tumor Diagnosis and Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Brain Tumor Diagnosis and Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2028
  6.3.2 US Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.3.3 Canada Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2028
  6.4.2 Germany Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.3 France Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.5 Italy Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.6 Russia Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2028
  6.5.2 China Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.3 Japan Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.6 India Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.3 Israel Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.5 UAE Brain Tumor Diagnosis and Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GE Healthcare
  7.1.1 GE Healthcare Corporate Summary
  7.1.2 GE Healthcare Business Overview
  7.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.1.4 GE Healthcare Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 GE Healthcare Key News
7.2 Hitachi
  7.2.1 Hitachi Corporate Summary
  7.2.2 Hitachi Business Overview
  7.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.2.4 Hitachi Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Hitachi Key News
7.3 Philips Healthcare
  7.3.1 Philips Healthcare Corporate Summary
  7.3.2 Philips Healthcare Business Overview
  7.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.3.4 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Philips Healthcare Key News
7.4 Siemens Healthineers
  7.4.1 Siemens Healthineers Corporate Summary
  7.4.2 Siemens Healthineers Business Overview
  7.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.4.4 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Siemens Healthineers Key News
7.5 Toshiba Corporation
  7.5.1 Toshiba Corporation Corporate Summary
  7.5.2 Toshiba Corporation Business Overview
  7.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.5.4 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Toshiba Corporation Key News
7.6 Fujifilm Corporation
  7.6.1 Fujifilm Corporation Corporate Summary
  7.6.2 Fujifilm Corporation Business Overview
  7.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.6.4 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Fujifilm Corporation Key News
7.7 Shimadzu Corporation
  7.7.1 Shimadzu Corporation Corporate Summary
  7.7.2 Shimadzu Corporation Business Overview
  7.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.7.4 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Shimadzu Corporation Key News
7.8 Merck & Co.
  7.8.1 Merck & Co. Corporate Summary
  7.8.2 Merck & Co. Business Overview
  7.8.3 Merck & Co. Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.8.4 Merck & Co. Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Merck & Co. Key News
7.9 AstraZeneca
  7.9.1 AstraZeneca Corporate Summary
  7.9.2 AstraZeneca Business Overview
  7.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.9.4 AstraZeneca Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 AstraZeneca Key News
7.10 Bristol Myer Squibb
  7.10.1 Bristol Myer Squibb Corporate Summary
  7.10.2 Bristol Myer Squibb Business Overview
  7.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.10.4 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Bristol Myer Squibb Key News
7.11 Novartis
  7.11.1 Novartis Corporate Summary
  7.11.2 Novartis Business Overview
  7.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.11.4 Novartis Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Novartis Key News
7.12 Roche Diagnostics
  7.12.1 Roche Diagnostics Corporate Summary
  7.12.2 Roche Diagnostics Business Overview
  7.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Major Product Offerings
  7.12.4 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Roche Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Brain Tumor Diagnosis and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Brain Tumor Diagnosis and Therapeutics Market Drivers in Global Market
Table 3. Brain Tumor Diagnosis and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Brain Tumor Diagnosis and Therapeutics in Global Market
Table 5. Top Brain Tumor Diagnosis and Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Brain Tumor Diagnosis and Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Brain Tumor Diagnosis and Therapeutics Product Type
Table 9. List of Global Tier 1 Brain Tumor Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Tumor Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Brain Tumor Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Brain Tumor Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Brain Tumor Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Brain Tumor Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. GE Healthcare Corporate Summary
Table 31. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 32. GE Healthcare Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Hitachi Corporate Summary
Table 34. Hitachi Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 35. Hitachi Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Philips Healthcare Corporate Summary
Table 37. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 38. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Siemens Healthineers Corporate Summary
Table 40. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 41. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Toshiba Corporation Corporate Summary
Table 43. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 44. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Fujifilm Corporation Corporate Summary
Table 46. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 47. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Shimadzu Corporation Corporate Summary
Table 49. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 50. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co. Corporate Summary
Table 52. Merck & Co. Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 53. Merck & Co. Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. AstraZeneca Corporate Summary
Table 55. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 56. AstraZeneca Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Bristol Myer Squibb Corporate Summary
Table 58. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 59. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Novartis Corporate Summary
Table 61. Novartis Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 62. Novartis Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Roche Diagnostics Corporate Summary
Table 64. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product Offerings
Table 65. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Brain Tumor Diagnosis and Therapeutics Segment by Type in 2021
Figure 2. Brain Tumor Diagnosis and Therapeutics Segment by Application in 2021
Figure 3. Global Brain Tumor Diagnosis and Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Brain Tumor Diagnosis and Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Brain Tumor Diagnosis and Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2021
Figure 8. By Type - Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Brain Tumor Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Brain Tumor Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. GE Healthcare Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hitachi Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co. Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AstraZeneca Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Novartis Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)